To verify whether tumor recovery is effectively driven by newly formed LGR5+ cells derived from differentiated LGR5−/KRT20+ cells, Shimokawa et al. generate KRT20-CreER knock-in lines of organoids to follow KRT20+ cell fate in vivo. This evidence concerns the gene LGR5 and neoplasm.